The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
Federal officials have approved new pain medication Journavx, designed to offer short-term pain relief without the addiction and overdose risks associated with opioids like Vicodin and OxyContin. The ...
Learn more about whether ICU Medical, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The VT Health Department, along with an Upper Valley nuring home is continuing to investigate the scoure of a Legionnaires’ outbreak.